These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 8389902)
1. Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection. Porter DC; Ansardi DC; Choi WS; Morrow CD J Virol; 1993 Jul; 67(7):3712-9. PubMed ID: 8389902 [TBL] [Abstract][Full Text] [Related]
2. Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans. Porter DC; Ansardi DC; Morrow CD J Virol; 1995 Mar; 69(3):1548-55. PubMed ID: 7853488 [TBL] [Abstract][Full Text] [Related]
3. Encapsidation and serial passage of a poliovirus replicon which expresses an inactive 2A proteinase. Ansardi DC; Pal-Ghosh R; Porter D; Morrow CD J Virol; 1995 Feb; 69(2):1359-66. PubMed ID: 7815522 [TBL] [Abstract][Full Text] [Related]
4. Expression of human immunodeficiency virus type 1 (HIV-1) gag, pol, and env proteins from chimeric HIV-1-poliovirus minireplicons. Choi WS; Pal-Ghosh R; Morrow CD J Virol; 1991 Jun; 65(6):2875-83. PubMed ID: 1851859 [TBL] [Abstract][Full Text] [Related]
5. Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans. Ansardi DC; Porter DC; Morrow CD J Virol; 1993 Jun; 67(6):3684-90. PubMed ID: 8388519 [TBL] [Abstract][Full Text] [Related]
6. A poliovirus minireplicon containing an inactive 2A proteinase is expressed in vaccinia virus-infected cells. Pal-Ghosh R; Morrow CD J Virol; 1993 Aug; 67(8):4621-9. PubMed ID: 8392603 [TBL] [Abstract][Full Text] [Related]
7. Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins. Moldoveanu Z; Porter DC; Lu A; McPherson S; Morrow CD Vaccine; 1995 Aug; 13(11):1013-22. PubMed ID: 8525684 [TBL] [Abstract][Full Text] [Related]
8. Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag. Porter DC; Melsen LR; Compans RW; Morrow CD J Virol; 1996 Apr; 70(4):2643-9. PubMed ID: 8642700 [TBL] [Abstract][Full Text] [Related]
9. Inherent instability of poliovirus genomes containing two internal ribosome entry site (IRES) elements supports a role for the IRES in encapsidation. Johansen LK; Morrow CD J Virol; 2000 Sep; 74(18):8335-42. PubMed ID: 10954532 [TBL] [Abstract][Full Text] [Related]
10. Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation. Ansardi DC; Morrow CD J Virol; 1993 Dec; 67(12):7284-97. PubMed ID: 8230452 [TBL] [Abstract][Full Text] [Related]
11. Demonstration of the specificity of poliovirus encapsidation using a novel replicon which encodes enzymatically active firefly luciferase. Porter DC; Ansardi DC; Wang J; McPherson S; Moldoveanu Z; Morrow CD Virology; 1998 Mar; 243(1):1-11. PubMed ID: 9527910 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the expression and immunogenicity of poliovirus replicons that encode simian immunodeficiency virus SIVmac239 Gag or envelope SU proteins. Anderson MJ; Porter DC; Moldoveanu Z; Fletcher TM; McPherson S; Morrow CD AIDS Res Hum Retroviruses; 1997 Jan; 13(1):53-62. PubMed ID: 8989427 [TBL] [Abstract][Full Text] [Related]
13. The RNA encompassing the internal ribosome entry site in the poliovirus 5' nontranslated region enhances the encapsidation of genomic RNA. Johansen LK; Morrow CD Virology; 2000 Aug; 273(2):391-9. PubMed ID: 10915610 [TBL] [Abstract][Full Text] [Related]
14. Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions. Ansardi DC; Morrow CD J Virol; 1995 Mar; 69(3):1540-7. PubMed ID: 7853487 [TBL] [Abstract][Full Text] [Related]
15. Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles. Ansardi DC; Porter DC; Morrow CD J Virol; 1992 Jul; 66(7):4556-63. PubMed ID: 1318418 [TBL] [Abstract][Full Text] [Related]
16. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA. Ansardi DC; Luo M; Morrow CD Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243 [TBL] [Abstract][Full Text] [Related]
18. Construction and characterization of encapsidated poliovirus replicons that express biologically active murine interleukin-2. Basak S; McPherson S; Kang S; Collawn JF; Morrow CD J Interferon Cytokine Res; 1998 May; 18(5):305-13. PubMed ID: 9620357 [TBL] [Abstract][Full Text] [Related]
19. Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures. Ansardi DC; Porter DC; Morrow CD J Virol; 1991 Apr; 65(4):2088-92. PubMed ID: 1848318 [TBL] [Abstract][Full Text] [Related]
20. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1. Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]